So far, the available evidence suggests that the muscle mass lost during weight loss with incretin RAs is comparable to other interventions inducing weight loss, such as diet and bariatric surgery, and that it is an adaptive process, comparable to the reduction in LV mass upon arterial blood pressure lowering (84)
FDA status: Investigational New Drug, without marketing authorization
laboratory values [HbA1c, creatinine, eGFR, ALT, and high-density lipoprotein cholesterol (HDL-C) levels]
Patients who lose weight very quickly may unintentionally under-consume these nutrients, compounding mood changes
Side-by-side of two of the most-studied repair peptides mechanism, half-life, and the research models where each is most relevant